Gastric Cancer Clinical Trials in Beijing
19 recruitingBeijing, China
Showing 1–19 of 19 trials
Recruiting
Phase 2
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
AstraZeneca163 enrolled44 locationsNCT05702229
Recruiting
Phase 1Phase 2
Study for AZD4360 in Participants With Advanced Solid Tumours
Gastric CancerGastroesophageal-junction CancerBiliary Tract Cancer+1 more
AstraZeneca117 enrolled17 locationsNCT06921928
Recruiting
Phase 3
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Gastric CancerGastroesophageal-junction Cancer
Daiichi Sankyo726 enrolled250 locationsNCT06731478
Recruiting
Phase 3
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
Gastric CancerGastroesophageal-junction Cancer
AstraZeneca572 enrolled186 locationsNCT06346392
Recruiting
Phase 3
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
Gastroesophageal Junction AdenocarcinomaHER2-positive Gastric Cancer
AstraZeneca840 enrolled284 locationsNCT06764875
Recruiting
Phase 3
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Gastric CancerGastroesophageal-junction CancerHER2-positive Gastric Cancer+1 more
Shanghai Henlius Biotech550 enrolled208 locationsNCT06532006
Recruiting
Not Applicable
Digital Rehabilitation for Gastric Cancer Surgery After Neoadjuvant Therapy
Gastric Cancer
Beijing Friendship Hospital186 enrolled1 locationNCT07441850
Recruiting
Phase 3
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Esophageal CancerGastric CancerGastroesophageal Junction Adenocarcinoma
AstraZeneca2,130 enrolled230 locationsNCT07431281
Recruiting
Phase 1Phase 2
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
Gastric CancerEsophageal AdenocarcinomaPancreatic Ductal Adenocarcinoma+1 more
AstraZeneca280 enrolled25 locationsNCT06005493
Recruiting
Phase 3
Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC
Gastric Cancer
Jiangsu HengRui Medicine Co., Ltd.550 enrolled1 locationNCT04342910
Recruiting
Phase 2
A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing Tumors
Advanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer)
AstraZeneca175 enrolled31 locationsNCT06271837
Recruiting
Real-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in China
HER2-positive Gastric CancerHER2-positive Gastroesophageal Junction
Daiichi Sankyo260 enrolled36 locationsNCT06846996
Recruiting
Phase 2
PD-1 Antibody Carilizumab Combined with Apatinib for Unresectable Stage III and IV DMMR Gastric Cancer
Gastric Cancer
Peking University Third Hospital20 enrolled1 locationNCT06792162
Recruiting
Phase 1Phase 2
Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination with XELOX or Irinotecan in Patients with Advanced Gastric Cancer
Gastric Cancer
Idience Co., Ltd.100 enrolled14 locationsNCT04725994
Recruiting
Phase 2
Neo-Sequence 2：NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGC
Gastric CancerDiffuse Type Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences67 enrolled1 locationNCT06371586
Recruiting
Not Applicable
Transhiatal Tunnel Valvuloplasty for Reconstruction Following the Laparoscopic Proximal Gastrectomy
Gastric Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences30 enrolled1 locationNCT06354036
Recruiting
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Gastric CancerImagePathology
Chinese Academy of Sciences200 enrolled22 locationsNCT06035250
Recruiting
Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics
Gastric CancerPeritoneal Metastases
Chinese Academy of Sciences400 enrolled13 locationsNCT05722275
Recruiting
Early Phase 1
NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors
Pancreatic CancerGastric CancerSolid Tumor
jianming xu18 enrolled1 locationNCT05583201